/
We are a novel ablation company committed to health innovation using our patented Nano-pulse Stimulation ( NPS ) technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to nonthermally clear or kill targeted cells. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation ( nsPFA …
The business is unprofitable at the operating level (-21982.57% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
ROIC dropped from -50.14% to -57.36%, capital efficiency is deteriorating. Negative free cash flow of -$54M. The business is consuming cash, not generating it.
Profitability & Returns
Revenue (TTM)
$751K
Net Income (TTM)
-$75M
▼ -35.8% YoY
Op. Margin
-10392.14%
ROIC
-65.77%
▼ -7.2pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-$55M
▼ -49.3% YoY
Op. Cash Flow (TTM)
-$55M
▼ -48.9% YoY
Net Debt
-$61M
Net Cash Position
Cash & Equiv.
$68M
Continue Research